Medical device and MedTech insights, news, tips and more

Synaptic Medical Appoints Robert Ricker as President of US Commercialization

November 20, 2019

Synaptic American President

LAKE FOREST, Calif., October 24, 2019 – Synaptic Medical, a medical device company that focuses on developing breakthrough products for the treatment of arrhythmias and other cardiovascular diseases, today announced that Robert C. Ricker has been appointed President of US Commercialization. Mr. Ricker’s broad executive experience in the cardiovascular industry are invaluable to the future success of Synaptic.

Sophia Wang, CEO of Synaptic, said that she and her colleagues are excited to bring Robert on board, noting that his cardiovascular expertise and understanding of the cardiovascular market will be invaluable for the company’s future growth. “We are pleased to welcome Mr. Ricker to Synaptic as part of our commitment to treating cardiovascular disease in the US”

Robert Ricker most recently served as senior vice president for Asahi Intecc. In this role, Mr. Ricker’s responsibilities included founding and leading all commercial functions, and commercial performance of the coronary, peripheral, and neurovascular segments. Prior to that, Mr. Ricker had roles of increasing responsibility within Asahi Intecc as well as positions with Abbott Vascular.

Robert received a bachelor’s degree in Marketing from Salisbury State University in Maryland, and an MBA from the University of Southern California.

About Synaptic Medical
Synaptic Medical is a medical device company focused on developing and commercializing breakthrough products for the treatment of cardiac arrhythmias and other cardiovascular diseases. Our mission is to develop unique, cost-effective, and clinically advanced technologies with the highest quality to enable physicians to optimize and expand treatment options. The company was founded in 2005 in Minnesota. Learn more at synapticmed.com.

The search was handled by Paula Rutledge and Joy Celebre of Legacy MedSearch, named to Forbes 2019 Americas Best Executive Recruiting Firms.


Press Release by Synaptic Medical and Legacy MedSearch


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.